Successful treatment of atrial flutter by repeated intraperitoneal and intra-amniotic injections of amiodarone in a fetus with hydrops

• Main Authors: Pei-Hsuan Lin, Hsin-Hung Wu, Horng-Der Tsai, Charles Tsung-Che Hsieh
• Format: Article
• Language: English
• Published: Elsevier 2016-06-01
• Series: Taiwanese Journal of Obstetrics & Gynecology
• Subjects: amiodarone; fetal atrial flutter; fetal direct treatment; hydrops fetalis
• Online Access: http://www.sciencedirect.com/science/article/pii/S1028455916300444

Objective: We report a case of nonimmune hydrops fetalis caused by atrial flutter, which was successfully treated by intraperitoneal and intra-amniotic injections of amiodarone. Case Report: A 27-year-old woman presented at 30 weeks of pregnancy with hydrops fetalis caused by a fetal atrial flutter. As the transplacental passage of antiarrhythmic agents is impaired in hydrops fetalis, we chose direct treatment using fetal intraperitoneal and intra-amniotic injections (75–300 mg) of amiodarone. We managed to successfully convert the fetal atrial flutter to normal sinus rhythm. The woman delivered a live female baby at 33 weeks of gestation with normal sinus rhythm and neurological development. Conclusion: Intrauterine antiarrhythmic treatment can reduce perinatal morbidity and mortality. This report suggests that direct fetal therapy using intraperitoneal or intra-amniotic injections of amiodarone constitutes an effective treatment for atrial flutter in cases of hydrops fetalis.